Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The sutureless connector (sc) intrathecal catheter connector has been redesigned to reduce the potential for occlusion at the catheter to pump interface. sc catheters are used with medtronic synchromed implantable drug infusion pumps. medtronic is removing unused products from the market that were manufactured with the previous design and recommends the previous design no longer be used due to greater potential for misalignment and subsequent occlusion. medtronic will exchange any unused sc intrathecal catheters with the updated products. all sc catheter products with a use by date prior to august 25 2014 are affected by this action.
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.